Postoperative Intermittent Intrauterine Balloon Dilatation Therapy.
Launched by FU XING HOSPITAL, CAPITAL MEDICAL UNIVERSITY · Apr 24, 2017
Trial Information
Current as of May 08, 2025
Completed
Keywords
ClinConnect Summary
Patients
The patients will be recruited from the Hysteroscopy Center of the Fuxing Hospital, Beijing, China. Before the surgery all patients with suspected Asherman syndrome will undergo preoperative evaluations, including a detailed history of the menstrual pattern, any previous intrauterine surgery, and reproductive history, as well as trans-vaginal ultrasonography. The severity and extent of intrauterine adhesions will be scored according to a classification system recommended by the American Fertility Society (AFS) (1988 version). The inclusion criteria include \[1\] women aged 18-40 y...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. women aged 18-40 years;
- • 2. moderate to severe intrauterine adhesion (AFS score≥5);
- • 3. no previous history of hysteroscopic adhesiolysis in our hospital;
- • 4. written consent obtained
- • 5. agreement to have second-look and third-look hysteroscopy.
- Exclusion Criteria:
- • 1. minimal adhesion (AFS score \<5);
- • 2. previous hysteroscopic adhesiolysis in our hospital.
About Fu Xing Hospital, Capital Medical University
Fu Xing Hospital, affiliated with Capital Medical University, is a leading medical institution dedicated to advancing healthcare through rigorous clinical research and innovative patient care. Renowned for its commitment to medical excellence, the hospital fosters a collaborative environment that integrates clinical practice, education, and research. With a focus on ethical standards and patient safety, Fu Xing Hospital actively engages in a diverse range of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. The institution's strong academic foundation and experienced research team contribute to its reputation as a trusted sponsor in the clinical trial landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
Tinchiu Li
Study Chair
Fuxing Hospital,Capital Medical University,China
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials